Skip to main content
Clinical Trials/NL-OMON56415
NL-OMON56415
Recruiting
Not Applicable

Effect of an immune-supportive diet on gut permeability and allergic symptoms in children with peanut and/or nut allergy. - Diameter study

OLVG0 sites132 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
peanut and nut allergy
Sponsor
OLVG
Enrollment
132
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
OLVG

Eligibility Criteria

Inclusion Criteria

  • \- Children of 3 \- 18 years of age with a positive open or double\-blind
  • placebo\-controlled peanut or nut challenge \< 24 months to inclusion;
  • an obvious and objective IgE\-mediated allergic reaction following the
  • consumption of isolated peanut or nut within 1 hours, confirmed by
  • sensitisation to peanut or nut \< 24 months to inclusion;
  • \- Children who are potty trained or house trained;
  • \- Presence of specific IgE to peanut or a nut \>\=0\.35 kU/l or skin prick test \>
  • 3 mm to peanut or nut, determined \< 24 months prior to

Exclusion Criteria

  • \- Only mild symptoms in the oral cavity to peanut or nut due to pollen food
  • \- A negative peanut or nut challenge;
  • \- Children who are not potty trained (house trained);
  • \- Gastro\-intestinal diseases (e.g. Morbus Crohn, celiac disease, Colitis
  • Ulcerosa), lactose\-intolerance, severe cow's milk allergy
  • genetic syndromes, infectious/immunology diseases other than atopy, or
  • \- Use of laxantia, such as lactulose;
  • \- Not being able to read or write Dutch

Outcomes

Primary Outcomes

Not specified

Similar Trials